SR2B Overview

  • Founded
  • 1984
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 4
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

SR2B General Information

Description

Developer of reagents in the fields of microbiology and parasitology. The company's biological based innovation help in the development of parasitic and fungal antigens or monoclonal antibodies, lyophilization of bioproducts, coupling of microparticles with macromolecules.

Contact Information

Website
www.sr2b.fr
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Acquirer
Primary Office
  • ZI Career Beurrière
  • 49240 Angers
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SR2B Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SR2B‘s full profile, request access.

Request a free trial

SR2B Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial